Stay updated on Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page.

Latest updates to the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange Detected- Added a dedicated Locations section with New Jersey and New York sites and updated the revision to v3.3.3. - Removed the separate New Jersey Locations and New York Locations entries and the HHS Vulnerability Disclosure link, reflecting the updated structure.SummaryDifference0.3%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedPublications section now states that publications are automatically filled from PubMed, and the Revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check47 days agoChange DetectedDeletion of the government funding notice banner that warned about delays in website updates, transactions, and inquiries. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check68 days agoChange DetectedThe study page content appears unchanged; any differences are limited to formatting or UI elements. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check90 days agoChange Detected- Added a government funding lapse notice and operational status details for the NIH Clinical Center, plus a new version tag v3.2.0. - Removed the old version tag v3.1.0.SummaryDifference2%

- Check97 days agoChange DetectedPage metadata updated: version bump to v3.1.0 with new date ranges; some past metadata removed and new future dates added. Overall, no substantive changes to core content or offerings.SummaryDifference0.6%

Stay in the know with updates to Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page.